
Lotte Biologics held the completion ceremony for Plant 1 at its Songdo Bio Campus on the 18th, firing the starting gun for its biologics CDMO (Contract Development and Manufacturing Organization) business.
Construction of Lotte Biologics' Songdo Bio Campus Plant 1 began in March 2024. With a total floor area of approximately 99,558 square meters, the facility obtained usage approval last June after just over three years. It is equipped with key facilities including production buildings, utility buildings, welfare facilities, and a wastewater treatment plant, securing a total biologics production capacity of 120,000 liters.
Starting with Plant 1, Lotte Biologics plans to sequentially construct Plants 2 and 3 (each with a capacity of 120,000 liters) to expand its total production capacity to 360,000 liters. Based on a "Dual-Site" strategy that links the commercial production experience of its U.S. Syracuse Bio Campus with the large-scale production capabilities of the Songdo Campus, the company aims to minimize technology transfer risks while pursuing diversification of its global supply chain.
On the 17th, ahead of the plant completion, Lotte Biologics successfully signed a contract manufacturing (CMO) agreement with a global pharmaceutical company, demonstrating market confidence in its process technology and business stability. A Lotte Biologics official stated, "We will provide 'one-stop services' ranging from clinical material production to large-scale commercial drug substance (DS) and clinical finished dosage forms." The official added, "Following usage approval, we are currently proceeding with preparation procedures such as equipment qualification and validation, and plan to begin full-scale commercial production next year."
At the completion ceremony, Park James, President of Lotte Biologics, stated, "Plant 1 at the Songdo Bio Campus achieved Good Manufacturing Practice (GMP) readiness six months ahead of the original schedule." He added, "This will serve as a solid foundation for growth to take another step forward in the global market."
President Shin Yu-yeol also delivered a congratulatory speech, stating, "The completion of the Songdo Bio Campus is meaningful not only as the completion of new production facilities but also because it lays the groundwork for Lotte Biologics to contribute to enhancing the large-scale production capabilities of South Korea's bio industry." He emphasized, "Based on quality, technology, and trust, we will become a CDMO partner that walks with our customers from a long-term perspective."
Lotte Group Chairman Shin Dong-bin stated, "The bio business is a future growth driver for Lotte Group." He expressed his expectation that "Plant 1 at the Songdo Bio Campus will serve as an important turning point to elevate the competitiveness of South Korea's bio industry beyond just Lotte Group." He added, "We will create high-quality jobs and cultivate outstanding specialized bio talent centered on Songdo," and further stated, "We will work closely with the government, relevant agencies, customers, and partners to contribute to the development of the domestic bio industry and strengthening national competitiveness."
Approximately 300 people attended the completion ceremony, reflecting high interest in K-CDMO. Attendees included key executives, Park Chan-dae, Mayor of Incheon; Song Young-gil, Member of the National Assembly for Incheon Yeonsu-gu (A); Jung Il-young, Member of the National Assembly for Incheon Yeonsu-gu (B); Lee Min-woo, Director of the Industrial Growth Division at the Ministry of Trade, Industry and Energy; Jeong Kyung-sil, Director of the Health Policy Division at the Ministry of Health and Welfare; Kim Jong-cheol, Head of the Incheon Free Economic Zone Authority; and Andrew Gately, Commercial Counselor at the U.S. Embassy in South Korea.
Prime Minister Han Seong-sook delivered a video congratulatory message, stating, "Lotte Biologics' Songdo Plant 1 is the first fruit of Lotte Group's bold investment in the bio industry with an eye on the future, and it will inject new vitality into South Korea's bio industry," expressing her expectations. Mayor Park Chan-dae also said in his speech, "Songdo Plant 1 is a vital asset for Incheon to leap forward as a global hub for the bio industry." He added, "The synergy between Incheon's research and development and talent cultivation infrastructure and Lotte Biologics' global production capabilities will enhance competitiveness in the bio industry."